成纤维细胞生长因子21在酒精性肝纤维化形成中的作用

肝脏 ›› 2017, Vol. 22 ›› Issue (12): 1098-1102.

成纤维细胞生长因子21在酒精性肝纤维化形成中的作用

田淑霞,阮君,肖铁钢,韩永龙,杜江,陈珺明

201306 上海交通大学附属第六人民医院中医科;贵阳中医学院药学院(田淑霞)

收稿日期:2017-08-11 出版日期:2020-06-15 发布日期:2020-06-15
通讯作者: 陈珺明,Email:chjm2008@126.com
基金资助:
上海市科委中医引导项目(15401933500)

Role of fibroblast growth factor 21 in pathogenesis of alcoholic liver fibrosis

TIAN Shu-xia, RUAN Jun, XIAO Tie-gang, HAN Yong-long, DU Jiang, CHEN Jun-ming.

Department of traditional Chinese medicine, the Sixth People′s Hospital of Shanghai Jiaotong University, Shanghai 201306, China; Pharmacy Department, Guiyang College of Traditional Chinese Medicine, Guizhou 550002, China

Received:2017-08-11 Online:2020-06-15 Published:2020-06-15
Contact: CHEN Jun-ming, Email: chjm2008@126.com

摘要/Abstract

摘要： 目的探讨成纤维细胞生长因子-21(fibroblast growth factor21,FGF21)在酒精性肝纤维化形成中的作用。方法将80只雄性SD大鼠随机分为空白组(10只)、四氯化碳(CCl₄)组(10只)和造模组(60只)。造模组采用每日酒精混合物灌胃及1周两次微量CCl₄混合液腹腔注射,连续12周。分别于4、8、10、12周处死大鼠,观察大鼠肝组织病理学改变;采用免疫组化法、蛋白质印迹、荧光定量PCR检测FGF21蛋白和mRNA表达动态变化。结果与空白组比较,造模组肝纤维化程度明显加重;FGF21水平空白组为(0.23±0.01),造模组在第4周明显增加为(1.06±0.10),之后逐渐升高到第10周为(1.36±0.16),到12周时却明显下降为(1.08±0.11)。结论 FGF21在酒精性肝纤维化形成中具有重要作用,在肝损害过程中FGF21应激性升高,在FGF21分泌不足时出现明显的肝纤维化,增加FGF21可能是治疗酒精性肝纤维化的另一个靶点。

关键词: 酒精性肝纤维化, 成纤维细胞生长因子-21, 动态变化

Abstract: Objective To observe the dynamic variety of fibroblast growth factor 21 (FGF21) in the development of alcoholic liver fibrosis in rats, and further investigate the role of FGF21 in alcoholic liver fibrosis.Methods Male SD rats weighing 240-280g were randomly divided into blank group, carbon tetrachloride (CCl₄) group and model group. The model was built with 10 mL/kg of alcohol mixture (56 DEG of alcohol: corn oil: pyrazole =5∶1∶10) by gavage daily and 0.3 ml/kg CCl₄ mixture (CCl₄∶olive oil =1∶3) by intraperitoneal injection twice a week for 12 weeks. The rats were sacrificed at week 4, 8, 10 and 12, respectively. Pathological changes in liver tissue were observed. Immunohistochemistry, western blot and fluorescent quantitative polymerase chain reaction (PCR) were used to measure FGF21 expression.Results Compared with blank group, the severity of liver fibrosis in model group was significantly increased. Level of FGF21 was significantly increased at week 4 (1.06±0.10 vs 0.23± 0.01, P<0.05), and then gradually increased till week 10 (1.36±0.16 vs 1.06±0.10, P<0.05), while significantly decreased at week 12 compared with that at week 10 (1.08±0.11 vs 1.36±0.16, P<0.05).Conclusion FGF21 might play a key role in the development of alcoholic liver fibrosis. Level of FGF21 was elevated under stress during liver injury and decreased when fibrosis developed. Therefore, increasing the level of FGF21 might be a potential target for treatment of alcoholic liver fibrosis.

Key words: Alcoholic liver fibrosis, Fibroblast growth factor -21, Dynamic changes

田淑霞,阮君,肖铁钢,韩永龙,杜江,陈珺明. 成纤维细胞生长因子21在酒精性肝纤维化形成中的作用[J]. 肝脏, 2017, 22(12): 1098-1102.

TIAN Shu-xia, RUAN Jun, XIAO Tie-gang, HAN Yong-long, DU Jiang, CHEN Jun-ming.. Role of fibroblast growth factor 21 in pathogenesis of alcoholic liver fibrosis[J]. Chinese Hepatolgy, 2017, 22(12): 1098-1102.

参考文献

[1] Mutanen A, Heikkil P, Lohi J,et al.Serum FGF21 increases with hepatic fat accumulation in pediatric onset intestinal failure. J Hepatol,2014, 60:183-190.
[2] Fisher FM, Chui PC, Nasser IA, et al.Fibroblast growth factor 21 limits lipotoxicity by promoting hepatic fatty acid activation in mice on methionine and choline-deficient diets.Gastroenterology, 2014,147:1073-1083.
[3] Jiang S, Yan C, Fang QC, et al. Fibroblast growth factor 21 is regulated by the IRE1alpha-XBP1 branch of the unfolded protein esponse and counteracts endoplasmic reticulum stress-induced hepatic steatosis.J Biol Chem,2014,289:29751 -29765.
[4] Bobbert T, Schwarz F, Fischer-Rosinsky A, et al. Fibroblast growth factor 21 predicts the metabolic syndrome and type 2 diabetes in Caucasians. Diabetes Care,2013, 36: 145-149.
[5] Dushay J, Chui PC, Gopalakrishnan GS,et al.Increased fibroblast growth factor 21 in obesity and nonalcoholic fatty liver disease. Gastroenterology, 2010,139:456- 463.
[6] Kim KH, Lee MS.FGF21 as a Stress Hormone: The roles of FGF21 in stress adaptation and the treatment of metabolic diseases. Diabetes Metab J,2014,38: 245-251.
[7] 周婷婷,秦波,郑天鹏,等.非酒精性脂肪肝患者血浆FGF21水平及与肥胖、胰岛素抵抗关系研究.第三军医大学学报,2010,:265-268.
[8] Lj H,Fang Q,Gao F,et al. Fibroblast growth factor 21 levels are increased in nonalcoholic fatty liver disease patients and are correlated with hepatic triglyceride.J Hepatol,2010, 53:934-940.
[9] Li H, Dong K, Fang Q,et al.High serum level of fibroblast growth factor 21 is an independent predictor of non-alcoholic fatty liver disease: a 3-year prospective study in China.J Hepatol, 2013,58:557-563.
[10] Xu P, Zhang Y, Liu Y,et al. Fibroblast growth factor 21 attenuates hepatic fibrogenesis through TGF-β/smad2/3 and NF-κB signaling pathways. Toxicol Appl Pharmacol,2016,290:43-53.
[11] 陈珺明,田淑霞,邢练军,等.基质金属蛋白酶纤溶系统在大鼠酒精性肝纤维化形成中的作用.世界华人消化杂志,2013;21:1595-1601.
[12] Miller AM, Horiguchi N, Jeong WI, et al. Molecular mechanisms of alcoholic liver disease: innate immunity and cytokines. Alcohol Clin Exp Res,2011,35: 787-793.
[13] Li H, Zhang J, Jia W.Fibroblast growth factor 21: a novel metabolic regulator from pharmacology to physiology.Front Med,2013,7:25-30.
[14] Zhu S, Ma L, Wu Y, et al. FGF21 treatment ameliorates alcoholic fatty liver through activation of AMPK-SIRT1 pathway. Acta Biochim Biophys Sin (Shanghai), 2014,46: 1041- 1048.
[15] Ye X, Qi J, Ren G, et al. Long-lasting anti-diabetic efficacy of PEGylated FGF-21 and liraglutide in treatment of type 2 diabetic mice.Endocrine, 2015,49:683-692.
[16] Xu P, Ye X, Zhang Y, et al. Long-acting hypoglycemic effects of PEGylated FGF21 and insulin glargine in mice with type 1 diabetes. J Diabetes Complications, 2015,29:5-12.
[17] 杨美,郭晓东,周光德,等.血清FGF-21水平与非酒精性脂肪性肝病的相关性.肝脏,2015,20:686-690.
[18] Fisher FM, Chui PC, Antonellis PJ, et al. Obesity is a fibroblast growth factor 21 (FGF21)-resistant state.Diabetes. 2010,59: 2781-2789.
[19] So WY, Cheng Q, Chen L,et al. High glucose represses β-klotho expression and impairs fibroblast growth factor 21 action in mouse pancreatic islets: involvement of peroxisome proliferator-activated receptor γ signaling.Diabetes,2013,62:3751- 3759.
[20] 赵翠青.分泌型成纤维细胞生长因子21和19/15在酒精性肝病中的作用调节机制.吉林:吉林大学,2015.